Pzena Investment Management LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 96,598 shares of the company’s stock, valued at approximately $37,663,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $26,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare in the 1st quarter valued at $33,000. MCF Advisors LLC raised its position in HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares during the last quarter. Finally, MidFirst Bank purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $28,000. 62.73% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. TD Cowen reduced their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Mizuho dropped their price target on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. The Goldman Sachs Group reduced their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. Finally, Raymond James Financial set a $528.00 target price on HCA Healthcare in a report on Tuesday, July 7th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $465.59.
HCA Healthcare Stock Up 0.2%
HCA stock opened at $405.53 on Tuesday. The stock’s fifty day simple moving average is $394.30 and its 200-day simple moving average is $445.90. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock has a market capitalization of $87.80 billion, a price-to-earnings ratio of 13.58, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the previous year, the business earned $6.84 EPS. The firm’s revenue was up 8.7% on a year-over-year basis. As a group, analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
